UK markets closed

ADC Therapeutics SA (ADCT)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
4.3000-0.2700 (-5.91%)
At close: 04:00PM EDT
4.3600 +0.06 (+1.40%)
After hours: 06:17PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts6666
Avg. Estimate-0.42-0.41-1.84-1.57
Low estimate-0.48-0.47-2.14-1.94
High estimate-0.37-0.34-1.54-1.08
Year ago EPS-0.58-0.58-2.94-1.84
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts6666
Avg. Estimate19.02M20.07M77.7M92.26M
Low estimate18.2M19.2M75.5M85.6M
High estimate20.02M21M80M97.34M
Year ago sales41.55M15.16M69.56M77.7M
Sales growth (year/est)-54.20%32.40%11.70%18.70%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.46-0.63-0.5-0.56
Actual EPS-0.58-0.58-1.03-0.56
Difference-0.120.05-0.530
Surprise %-26.10%7.90%-106.00%0.00%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.42-0.41-1.84-1.57
7 days ago-0.55-0.53-2.15-1.78
30 days ago-0.55-0.53-2.14-1.81
60 days ago-0.46-0.47-1.85-1.55
90 days ago-0.46-0.47-1.88-1.65
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 days6555
Up last 30 days6555
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/A11N/A
Growth estimatesADCTIndustrySector(s)S&P 500
Current qtr.27.60%N/AN/AN/A
Next qtr.29.30%N/AN/AN/A
Current year37.40%N/AN/AN/A
Next year14.70%N/AN/AN/A
Next 5 years (per annum)15.80%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A